Trade Name: Astakof Active substance (INN): - Dosage form: syrup Composition: Each 5 ml contains: Active substances: Extract from the roots of licorice naked (Glycyrrhiza glabra) 140 mg Extract from the fruit of marshmallow officinalis (Althaea officinalis) 50 mg Extract from the fruits of Mallow forest (Malva sylvestris) 50 mg Extract from the leaves of Onosma bract (Onosma bracteatum) 50 mg Extract from the fruit of Zizypus real (Zizypus sativa) 30 mg Extract from the rhizomes of medicinal Ginger (Zingiber officinale) 70 mg Extract from the fruits of Long Pepper (Piper longum) 70 mg Extract from the fruits of Black Pepper (Piper nigrum) 70 mg Extract from the stem of Tinospora cordifolia (Tinospora cordifolia)150 mg Extract from the leaves of vascular Adhatoda (Adhatoda vasika) 300 mg Tamala Cinnamon Leaf Extract (Cinnamomum tamala) 50 mg Extract from the flowers of Hyssop officinalis (Hyssopus officinalis) 50 mg Extract from the leaves of Holy Basil (Ocimum sanctum) 200 mg Extract from the fruit of Embelia acid (Emblia ribes) 45 mg Extract from roots, fruits, seeds of Indian Nightshade (Solanum xanthocarpum)150 mg Extract from the seeds of real Cardamom (Elettaria cardemomum) 2 mg Extract from the fruits of cultivated grapes (Vitis venifera) 10 mg Guggul extract (resin) (Balsamodendron mukul) 10 mg Spearmint Dry Extract-crystals (Mentha spicata) 0.5 mg Auxiliary substances: Sodium benzoate 18 mg Sodium methyl parahydroxybenzoate 12 mg Sodium propylparahydroxybenzoate 1 mg Ammonium chloride 3 mg Citric acid 0.3% Flavor "Honey" 0.2 mg Sorbitol 100 mg Sugar 55.0 % Purified D.K. water up to 5,00 ml Description: brown syrup with a characteristic smell. Pharmacotherapeutic group: Herbal preparation used in ENT practice. ATX Code: RO5CA10
Pharmacological properties A combined herbal preparation; having broncholytic, mucolytic, expectorant and anti-inflammatory effects.
Pharmacokinetics: In accordance with the International Convention (EMEAHMPWG11/99), when conducting clinical trials of herbal preparations, an isolated study of pharmacokinetic parameters is not required. Indications for use As part of the complex symptomatic therapy of inflammatory diseases of the respiratory tract, accompanied by dry cough or cough with difficult-to-separate sputum, as well as spastic cough: bronchitis, the initial stages of whooping cough, cough relief for asthma and tuberculosis, tracheitis, tracheobronchitis, ARVI, influenza, pharyngitis, laryngitis, tracheitis, pneumonia, chronic respiratory diseases (bronchitis of smokers, lecturer's laryngitis).
Method of administration and dosage For infants: 5-10 drops 3-4 times a day, preferably together with 1 full teaspoon of water. Children: from 1 year to 3 years – by (2.5 ml) – 3 times a day; Children: from 3 to 12 years - 1/2 - 1 teaspoon (2.5 - 5 ml) 3 times a day; Children: from 12 years - 1 teaspoon (5 ml) 2-3 times a day; Adults: 1-2 teaspoons (5.0 - 10.0 ml) 2-3 times a day. Duration of application The course of treatment is 2-3 weeks. After the symptoms of the disease disappear, treatment should be carried out for another 2-3 days. An increase in the duration and repeated courses of treatment is possible on the recommendation of a doctor.
Side effects Allergic reactions are possible
Contraindications Hypersensitivity to the components of the drug.
Drug interactions Simultaneous administration with antitussive drugs is not recommended due to the possibility of violation of the discharge of liquefied sputum.
Special instructions Use of the drug during pregnancy and lactation : Safe during pregnancy and lactation Features of the impact on the ability to drive vehicles and other potentially dangerous mechanisms The drug does not affect the ability to drive vehicles and other potentially dangerous mechanisms.
Overdose Not identified. In case of overdose, treatment is symptomatic.
Release form Syrup for oral administration in a bottle of 100 ml with a screw-on protective cap. 1 bottle together with a leaflet and a measuring cup in a cardboard box.
Storage conditions Store in a dry place protected from light, at a temperature not exceeding 25 C. Keep out of reach of children.
Expiration date 3 years. Do not use after the expiration date
Conditions of release from pharmacies Without a prescription.
Manufacturer: Harasha Pharma Pvt. Ltd., Piyau Manihari, Nerela Road, Kundli Sonapet District (Haryana), India
Name and address of the organization accepting claims (proposals) on the quality of medicines in the territory of the Republic of Uzbekistan LLC "Astanova Healthcare" Tashkent, Yakkasaraysky district, Yakkasaroy str., house-5. Tel.: (+998) 71 253 22 37, (+998) 71 253 22 57. Sot.: (+998) 97 265 55 71.
